Table 2.
Comparability Critical Attributes | Similarity Demonstration |
---|---|
Protein structure and production quality | Extensive laboratory analysis for all molecular characteristics (multiple lots) |
Pharmacokinetics, Pharmacodynamics, and Animal Toxicity | In vitro and in vivo assays (carried out on relevant animal species, if further confirmation scans are required for laboratory studies) |
Pharmacokinetics, Pharmacodynamics, and Animal Toxicity | Phase I clinical studies |
Clinical Efficacy and Safety | Phase III clinical studies |
Safety in clinical practice | Risk management plan Phase IV studies Pharmacovigilance |